Publications

May 11, 2021

ASGCT – 2021 – Oral Presentation

Platform, Trem-cel

VOR33: A Clinic-Ready CRISPR/Cas9 Engineered Hematopoietic Stem Cell Transplant for the Treatment of Acute Myeloid Leukemia